Tyro announces director departure and share adjustments

Tyro Payments Limited announced the departure of director Jonathan Charles Davey, effective December 5, 2025. An Appendix 3Z filing confirmed his final director's interest notice, detailing direct holdings of 890,487 fully paid ordinary shares, 297,619 Medipass Performance Rights, and various STI Equity Rights across FY22, FY23, and FY24. Indirect interests included 179,381 ordinary shares held in escrow by Pacific Custodians Pty Ltd, related to a loan agreement with Tyro Health Pty Ltd for A$333,824.81.

In related announcements, Tyro also reported the cessation of 2,613,751 Performance Rights due to unmet conditions as of December 5, 2025, primarily from FY24 LTI and FY25 LTI grants following the employment cessation. Concurrently, 267,857 Performance Rights were converted into ordinary fully paid shares on the same date, stemming from past performance, with Jonathan Davey being the key management personnel involved in this conversion.

Following these capital adjustments, Tyro's issued capital now comprises 530,729,691 ordinary fully paid shares. The number of unquoted Performance Rights has decreased to 10,625,577, while other unquoted options remain as previously stated.